INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.490
-0.040 (-2.61%)
At close: Jan 9, 2026, 4:00 PM EST
1.500
+0.010 (0.67%)
After-hours: Jan 9, 2026, 5:27 PM EST
Revenue by Product
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.